Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (171-180 of 278) with videos related to

Pageof 28
Sort By:
Blood|April 17, 2009
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Dan Jones, et al.
Human Pathology|January 24, 2007
Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphomaAgnieszka Witkiewicz, Puthiyaveettil Raghunath, Agnieszka Wasik, et al.
American Journal of Clinical Pathology|April 17, 2010
Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related casesPranil Chandra, Rajyalakshmi Luthra, Zhuang Zuo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Expression of heat-shock protein-90 in non-Hodgkin's lymphomasJose R Valbuena, George Z Rassidakis, Pei Lin, et al.
BMC Medicine|September 27, 2019
Response to 'The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: a consensus statement' by Cumming et alMegan Wilson-Jones, Kyla Smith, Dan Jones, et al.
The Science of the Total Environment|September 1, 2021
Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United StatesYuehan Ai, Angela Davis, Dan Jones, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistanceWenyong W Zhang, Jorge E Cortes, Hui Yao, et al.
Archives of Pathology & Laboratory Medicine|May 7, 2021
Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive PatientsMaria Westerhoff, Dan Jones, Steven M Hrycaj, et al.
The American Journal of Surgical Pathology|April 17, 2004
Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphomaJoseph D Khoury, Dan Jones, Marwan A Yared, et al.
Pageof 28

Showing results (171-180 of 278) with videos related to

Sort By:
Pageof 28
Blood|April 17, 2009
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Dan Jones, et al.
Human Pathology|January 24, 2007
Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphomaAgnieszka Witkiewicz, Puthiyaveettil Raghunath, Agnieszka Wasik, et al.
American Journal of Clinical Pathology|April 17, 2010
Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related casesPranil Chandra, Rajyalakshmi Luthra, Zhuang Zuo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Expression of heat-shock protein-90 in non-Hodgkin's lymphomasJose R Valbuena, George Z Rassidakis, Pei Lin, et al.
BMC Medicine|September 27, 2019
Response to 'The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: a consensus statement' by Cumming et alMegan Wilson-Jones, Kyla Smith, Dan Jones, et al.
The Science of the Total Environment|September 1, 2021
Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United StatesYuehan Ai, Angela Davis, Dan Jones, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistanceWenyong W Zhang, Jorge E Cortes, Hui Yao, et al.
Archives of Pathology & Laboratory Medicine|May 7, 2021
Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive PatientsMaria Westerhoff, Dan Jones, Steven M Hrycaj, et al.
The American Journal of Surgical Pathology|April 17, 2004
Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphomaJoseph D Khoury, Dan Jones, Marwan A Yared, et al.
Pageof 28